Abstract: Epidemiological studies show that the risk for cardiovascular diseases increases with increasing levels of free-copper in plasma. It is known that intact ceruloplasmin (CP), the major protein transporter of copper in human plasma, oxidizes low density lipoproteins (LDL) in vitro. Our aim was to study the interaction between LDL and CP in vitro and in vivo, in an animal model of diet-induced atherosclerosis. In order to visualize the pathway of LDL into the arterial wall, human native LDL was labeled with fluorescent DiI and injected into male, Golden Syrian hyperlipemic hamsters. In vitro results demonstrated that slightly degraded CP has a significant oxidation potential against LDL at neutral pH. In vivo, after 24 hours circulation, LDL-DiI was taken up by the enlarged intima and fatty streaks of the arterial wall. Immunohistochemical localization of oxidized LDL and CP revealed their presence in the same areas of the arteries that take up LDL-DiI. Co-localization of LDL and CP in the enlarged intima of pro-atherosclerotic areas might explain the possible copper-induced oxidation process that might occur after native LDL is taken-up from the blood, transcytosed through the endothelium and accumulated in focalized deposits.
Introduction
Atherosclerosis is a complex multifactorial disease, which develops in the arterial wall in response to various stimuli and results in excessive inflammatory and fibroproliferative reactions. A characteristic sequence of events has been observed in all lesion-prone areas of the vasculature, including the cardiac valves, aortic arch, coronary and carotid arteries [1, 2] . These are the focal sites where atherosclerosis develops in humans, as well as in animal models of saturated fat-induced atherosclerosis, such as the hyperlipemic Golden Syrian hamster [3] . Plasma hyperlipemia generates increased transcytosis of atherogenic lipoproteins, leading to their accumulation within and outside the endothelial cell hyperplasic basement membrane, against the fragmented internal elastic lamina [4] . Modification of the low density lipoproteins (LDL), mostly by oxidation, is believed to play an important role in human atheroma formation [5] [6] [7] .
Extensive LDL oxidation in the atherosclerotic lesions may require a source of iron or copper as catalysts for the oxidation. The main copper carrier in plasma is ceruloplasmin (CP); it is an abundant, blue plasma protein (metalloenzyme) that possesses both anti-oxidant properties (e.g. ferroxidase activity) and pro-oxidant potential. Elevated circulating CP levels are associated with cardiovascular disease (CVD) [8] . There is also evidence that the risk factors for CVD, in particular, diabetes mellitus and hyperhomocysteinaemia, may augment the vasculopathic impact of CP [9] . Another possibility is for reactive oxygen species to disrupt copper bound to CP, thereby impairing the protective function of the latter, while liberating copper, which in turn may promote oxidative reactions [9] .
Our hypothesis was that in areas with increased trans-endothelial transport, an increased transport of native LDL and ceruloplasmin from the lumen into the arterial wall could take place and thus increase the oxidation of sub-endothelial LDL. Another source of ceruloplasmin could be the monocyte-derived macrophages [10] located in the fatty streak areas of the artery.
Looking for the impact of CP on transcytosed LDL accumulated in the arterial intima, we have first evaluated the potential and the necessary conditions for CP to induce LDL oxidation in vitro, and further immuno-localized LDL and CP in the arterial intima of hyperlipemic hamsters. Results show that in vitro incubation of native LDL (nLDL) with slightly degraded human CP (commercially available) at neutral pH induces the oxidation of LDL. Injection of fluorescently labelled human nLDL in the blood of hyperlipemic male Golden Syrian hamsters lead to the accumulation of lipoproteins within the enlarged intima and fatty streaks, where oxidized LDL (oxLDL) and CP have been colocalized.
Experimental Procedures

Materials
Ceruloplasmin was obtained from Calbiochem (La Jolla, CA, USA), 1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate (DiI) from Molecular Probes, USA. Enzymatic kits for cholesterol and triglycerides determination were purchased from Dialab (Austria), and 2,2'-diazobis (2-amidino-propane) dihydrochloride (AAPH) was purchased from Sigma -Aldrich (USA); 2,7-dichlorofluorescein-diacetate (DCFH-DA) and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxilic acid (Trolox) were obtained from Fluka Chemie, Germany. Other chemicals and reagents were purchased from Sigma (Saint Louis, MO, USA) if not otherwise stated.
The primary antibodies used were mouse monoclonal antibody anti-human oxLDL (a generous gift from Prof. Paul Holvoet) and whole serum goat anti-human CP (Sigma-Aldrich, USA). Goat anti-mouse and Rabbit anti-goat IgG conjugated with horseradish peroxidase (HRP) were the second antibodies used (Sigma-Aldrich, USA).
Animals
Adult (80-100 g body weight) male Golden Syrian hamsters were kept in standard housing conditions with free access to rodent chow and maintained on a 12 hours light/dark cycle. Animals were fed either standard chow (N) (n=10) or standard chow supplemented with 3% cholesterol and 15% butter (hyperlipemic, HL) (n=20).
All experimental procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the Institutional Animal Care and Use Committee, April 1997, Oakland University, USA.
LDL isolation
LDL was isolated from the plasma of healthy donors from the Blood Transfusion Center Bucharest by density gradient ultracentrifugation [11] . The LDL fraction was collected, dialysed against phosphate buffer saline (PBS), pH 7.4, at 4°C in the dark, stored under sterile conditions with EDTA (noxLDL) or EDTA and BHT (nLDL) and used within 7 days. Before use, LDL was dialysed against PBS, pH 7.4, at 4°C, in the dark, to remove EDTA.
In vitro modification of LDL
Copper-oxidized LDL was prepared by incubating noxLDL under sterile conditions with 10 µM copper chloride (24 hours, at 37°C), in the absence of antioxidant protection. The oxidative reaction was stopped by adding 1 mg/ml EDTA; after extensive dialysis against PBS, pH 7.4, 4°C, oxLDL was stored at 4°C, under sterile conditions and used within 7 days.
Fluorescent LDL preparation
Human LDL was labelled with DiI as described [12] . The integrity of LDL protein following DiI labelling was verified by denaturing polyacrilamide gel electrophoresis (SDS-PAGE).
Ceruloplasmin preparation
CP had an A610nm/A280 ratio of 0.02 which is consistent with a slightly degraded copper-protein complex [13] . SDS-PAGE indicated a major molecular weight band of 132,000 kDa. CP was pre-incubated (400 µg/ml) in 50 mM phosphate buffer (PB) at either pH 7 or pH 5, for 24 hours, at 37°C. It was then incubated with either nLDL, or noxLDL, using a ratio of 200 µg CP/mg LDLcholesterol, similar to the physiological conditions.
Characterization of CP-modified LDL
Lipid peroxides were evaluated spectrofluorimetrically using excitation at λ=360 nm and emission at λ=430 nm. The protein degradation of LDL was measured by following the decrease of tryptophane fluorescence (Ex 295 nm/Em 360 nm). The lipid peroxides level was determined as thiobarbituric acid reactive substances (TBARS) and expressed as nmoles malondialdehyde (MDA)/mg LDL-cholesterol [14] . The electric charge of noxLDL and nLDL was determined by agarose gel electrophoresis (0.6%) and expressed as relative electrophoretic mobility (Rf). SDS-PAGE was employed to characterize apoB from LDL.
Serum assays
Blood was collected from the venous orbital plexus of fasted animals (lightly anesthetized with 50 mg chloral hydrate/100 g body weight) and processed for determination of total cholesterol, triglycerides, total antioxidant trapping potential (TRAP), and total lipid peroxides (TBARS). TRAP was determined as described by Niculescu et al. [15] .
Tissue preparation for light microscopy
Hamsters were anesthetized and after laparatomy and catheterization of the abdominal aorta, and the blood was perfusion-washed with PBS supplemented with 0.1% CaCl 2 and 2.25% glucose at 37°C, for 10 min (4 ml/minute) using the vena cava as an outlet. Under the same conditions, a mixture of 2% paraformaldehyde in 0.1 M PB, pH 7.4, or PLP fixative (Nakane's fixative: 2% paraformaldehyde and 0.075 lysine in 0.01 M Na periodate) was perfused. After 10 min of in situ fixation under normal pressure, the aortic arches were kept in the same fixative for another 2 to 4 h at room temperature. After washing with PBS, specimens were immersed in PBS containing 5%, 10%, and 20% sucrose with 10% glycerol at 4ºC for 15 min, 1 h, and 10 h, respectively. Specimens were frozen in isopentane cooled with liquid nitrogen and stored at -70°C. Thick sections (5-10 µm) from the OCT embedded samples were cut on a Harris cryostat at -30°C and mounted on 2% gelatine-coated slides.
In vivo uptake of LDL-DiI
LDL-DiI was administrated intravenously to animals under anaesthesia and maintained in the circulation for 24 h. The hamsters were then sacrificed, the abdominal aorta catheterized and the vasculature perfusion-washed with PBS pH 7.4 at 37°C, using vena cava as outlet, followed by perfusion-fixation with 2% paraformaldehyde for 10 min. The aortic arches were collected for freezing and cryosectioning.
Immunohistochemical localization of LDL and CP
Both hamster LDL and CP gave a single precipitation line with anti-human oxLDL and anti-human ceruloplasmin, respectively, as verified by Ouchterlony double immunodiffusion (data not shown).
To immuno-localize oxLDL and CP, an indirect immunoperoxidase procedure was used [16] . Briefly, after fixation the residual aldehyde groups were quenched with 0.05 M NH 4 Cl in 0.01 M PBS, pH 7.4, for 20 min at room temperature. Endogenous peroxidase activity was quenched with 0.3% H 2 O 2 applied on sections for 10 min. Non-specific binding was blocked by specimens' incubation with 10% normal goat or mouse serum for 30 min or with 1% ovalbumin from chicken egg in PBS, for 20 min at 22°C. Serial cryosections were incubated with either monoclonal antibody to oxLDL, antiserum to CP, or control solutions for 18 h at 4°C, in moisture chamber. These were followed by a second antibody, goat antimouse or rabbit anti-goat IgG conjugated to HRP, for 2 h at 37°C. The specimens were then incubated with 0.2% diaminobenzydine dihydrochloride (DAB) in TrisHCl 0.05 M, pH 7 with 0.01% H 2 O 2 for 1 min and the reaction was stopped with 0.05 M Tris-HCl (pH 7.4). Each incubation step was followed by washing with PBS, with 0.05 M Tris-HCl (pH 7.4) (for immunoperoxidase). Sections were mounted in glycerol-PBS and examined with a light microscope (Nikon) in phase-contrast system. Control experiments included the following cases: (i) substitution of the first antibody with nonimmune serum, (ii) omission of the primary antibody and the use of the secondary antibody only, and (iii) omission of both primary and secondary antibodies and use of HRP-reaction product (DAB/H 2 O 2 ) alone.
Statistical analysis
All data are presented as means ± SEM; where n is the number of experiments. Statistical significance was determined by Student's t test for independent samples; P<0.05 was considered statistically significant.
Results
LDL interaction with ceruloplasmin in vitro
In order to evaluate the potential of CP to oxidize LDL, nLDL or noxLDL were incubated with CP that was preincubated 24 h in PB, at either pH 7 or pH 5. The data were compared with those corresponding to copperoxidized LDL. Incubation of CP (2 µM, pre-incubated at neutral pH) with noxLDL induced 100-fold increase of the lipid peroxides compared to noxLDL in neutral PB (TBARS values 15.3±0.34 versus 0.12±0.017 nmoles MDA/mg LDL-cholesterol, P<0.001) ( Figure 1A ). This effect was higher than that of 10 µM copper incubated with noxLDL (TBARS value 4.06±0.02 nmoles MDA/mg LDL-cholesterol). Spectrofluorimetric determination of the lipid peroxides (Ex 360 nm/Em 420 nm) in the CPoxidized noxLDL showed a 10-fold increase compared with noxLDL in PB (5,054±521 versus 448±54 RFU, P<0.001). A three fold increase of the protein degradation was observed in CP-oxidized noxLDL (8,402±866 versus 27,775±1,863 RFU for noxLDL in PB, P<0.001), comparable with that for copper oxidized LDL (an 8-fold increase of the lipid peroxides, 3839±396 RFU, P<0.001), and a four fold increase of the protein degradation (6829±704 RFU, P<0.001). Using SDS-PAGE electrophoresis, we demonstrated the degradation of apoB from CP-oxidized noxLDL (data not shown). No effect was induced by CP on nLDL (data not shown).
The CP pre-incubated at acidic pH induced a 2-fold increase of the lipid peroxides level in noxLDL (23.44±0.7 versus 10.9±0.2 nmoles MDA/mg LDL-cholesterol in noxLDL plus PB at pH 5, P<0.001) ( Figure 1B) . Spectrofluorimetric determination of the lipid peroxides and of the protein degradation in noxLDL incubated with acidic CP revealed no significant increase of the lipid peroxides, but a slight increase of the protein degradation (3712±383 versus 1126±116 RFU). Spectrofluorimetric determination of the lipid peroxides and of the protein degradation in nLDL incubated with acidic CP revealed no significant effect, results also supported by SDS-PAGE (data not shown). The acidic CP did not induce a significant increase of TBARS in nLDL.
The modifications induced by CP in noxLDL were confirmed by the variation of the electrophoretic mobility (Rf) in agarose gel. The noxLDL incubated with neutral CP had a double Rf compared to noxLDL in PB, pH 7.4 (0.41±0.022 versus 0.23±0.018). No change of the Rf value was observed for nLDL incubated with CP ( Figure 2A ). This effect was comparable to that in copper oxidized LDL, where Rf increased 1.8-fold. The Rf of noxLDL incubated with acidic CP was not significantly modified ( Figure 2B ). 
In vivo LDL interaction with CP in the intima
After 16 weeks of hyperlipemic diet, hamsters had a mean serum cholesterol level of 809±103 mg/dl, P<0.001 (8 times the normal value 105±20 mg/dl) ( Figure 3A) . The increase of triglycerides concentration paralleled the increase of cholesterol, from 138±20 mg/dl serum (week 0) to 803±92 mg/dl, P<0.001 (week 16) ( Figure 3A) . Serum lipid peroxides increased slowly for 8 weeks (from 1.64±0.15 nmoles eq MDA/ml at week 0 to 6.8±1.0 nmoles eq MDA/ml at week 8) and then remained constant, while the total antioxidant potential showed a constant decrease (from 1045±74.6 µmoles/L at the beginning of diet to 574±45 µmoles/L after 16 weeks of diet) ( Figure 3B ).
The increase of serum cholesterol and TG concentrations was accompanied by structural changes of the arteries, the formation of an enlarged intima, the appearance of fatty streaks, and later, of the atheroma. The sequence of cellular events occurring in lesionprone areas was as previously reported for the HL hamster [3] .
Fluorescent (DiI) labelling of human nLDL did not change the characteristics of the lipoproteins, as evidenced by agarose electrophoresis, double immunodiffusion and SDS-PAGE (data not shown). We have demonstrated that the presence of a 10-fold excess unlabelled nLDL together with LDL-DiI in the culture medium of smooth muscle cells induced a 50% decrease of the uptake of LDL-DiI, while a 10-fold excess of acetylated-LDL did not affect the LDL-DiI uptake (data not shown).
We followed the in vivo transport of LDL in lesionprone areas of the aortic arch by following the pathway of LDL-DiI after intravenous injection and 24 hours circulation in blood. After 24 hours in vivo recirculation, the transcytosed LDL-DiI accumulated in the enlarged intima and fatty streaks of the aortic arch, as deposits associated with foam cells, most probably derived from lipid-loaded macrophages ( Figure 4A and 5A) . Injection of the fluorescent conjugate in N hamsters led to undetectable LDL-DiI uptake in the similar vascular segments ( Figures 4D and 5D ). The grossly normal areas proximal to the fatty streaks of the aortic arch from HL animals showed a weak red fluorescence as opposed to similar regions from N animals. The uptake of LDL-DiI was limited to the fatty streak level, which was intensely marked by the red fluorescence and restricted by the internal elastic lamina.
The presence of oxLDL was immunodetected in the lesion-prone areas of the aortic arch, showing intense labeling in the fatty streaks and weak labeling in the grossly normal intima from HL animals ( Figure 4B ). OxLDL deposits were immuno-detected in the intima of HL hamsters aortic arch, and were co-localized with LDL-DiI fluorescent deposits ( Figure 4A ). Cryosections from similar vascular segments from N animals lacked staining with the antibody against oxLDL ( Figure 4E ).
The immunohistochemical detection of CP in the HL hamsters aortic arch evidenced a strong, focal staining (dark brown reactive HRP) in the fatty streaks ( Figure 5B ) where transcytosed LDL-DiI were accumulated ( Figure 5A) . A weak CP staining marked the grossly normal intima from the HL animal. In N animals, no detectable CP immunostaining in the intima of similar vascular segments was found ( Figure 5E ). Control cryosections (omission of the primary antibody for both oxLDL and CP, the use of non-immune serum instead of the first antibody) gave negative results ( Figures 4C, 4F, 5C and 5F ).
An interesting observation was that both oxidized LDL and CP immunostaining were limited to the area of the intima, and only rarely were light and diffuse staining of the media observed.
Discussion
Little information regarding the in vivo interaction of CP (either intact or degraded) with LDL in the arterial wall is available. We looked for the oxidative effect of CP on LDL and demonstrated that slightly degraded CP induces LDL oxidation in the absence of antioxidant protection. Furthermore, we performed in vivo experiments to follow LDL pathway in the vascular wall and established a co-localization of oxidized LDL and CP in the enlarged intima of hyperlipemic hamsters.
The mechanisms by which LDL are oxidized in the arterial wall are not fully understood, but they might involve the cumulative effect of reactive oxygen or nitrogen species generated by inflammatory cells, enzymatic oxidation, or of the existence of catalytically active transition metal ions [17] . It is known that copper is more potent than iron in catalyzing cellular LDL oxidation [18] and thus can account for the initiation of oxidation of LDL present in the arterial wall. Existing data show that CP and/or copper levels are increased in plasma from subjects with CVD [8] . In addition, a correlation between plasma levels of CP and levels of autoantibodies against oxLDL suggests a possible prooxidant activity of CP in vivo [19] .
In the present study, we report that human CP, even if slightly degraded, incubated with LDL oxidizes the lipoproteins after 24 hours incubation at neutral pH, 37ºC, in the absence of antioxidants, while in their presence the oxidation is abolished. Previously, in similar conditions, Ehrenwald et al. [20] demonstrated that intact CP isolated from human plasma oxidizes LDL. In contrast, using commercially available, undegraded CP, Lamb and Leake [21] demonstrated that CP does not modify LDL in the presence of cultured macrophages, unless CP was pre-incubated at acidic pH. Their suggestion is that copper atoms tightly bound to CP at neutral pH are not able to catalyse LDL oxidation, while at acidic pH, CP releases or activates different types of copper atoms and oxidizes LDL.
Data from biochemical assays evidence that human atherosclerotic plaques contain CP and catalytically active copper ions [8] , but there are no reports about the localization of CP in the intima of the arterial wall. CP could accumulate in the vessel wall by uptake through a specific receptor described on the endothelium by Tavassoli et al. [22] or by secretion from macrophages in the vascular lesions.
In order to establish the localization of the CP in normal or hyperlipemic arteries, we used an animal model of fat-induced atherosclerosis, the hyperlipemic hamster. Hamsters respond to hyperlipemia by considerable increase of the total cholesterol and triglycerides in serum, and by developing aortic, valvular and coronary artery lesions that resemble human atherosclerotic plaques [3] . In addition, HL hamsters developed a significant decrease of TRAP levels and increase of TBARS values in the sera during the weeks of diet [15] . We have previously shown that the increase of serum cholesterol was generated by the increase of LDL-cholesterol concentration and the increased transport of LDL in HL hamsters [23] . After 24 hours in circulation, fluorescent LDL conjugated to DiI, accumulated in enlarged intima and fatty streaks of the aortic arch of HL hamsters, but was undetectable in similar areas of N hamsters. Our results show that in hyperlipemic conditions, the intima in lesion-prone regions of the arteries presents an increase of nLDL transport, evidenced by the accumulation of injected LDL-DiI in the sub-endothelium. These results are in agreement with those of other groups showing an increased permeability (for review see [24] ).
OxLDL was detected immunohistochemically in the enlarged intima and fatty streaks of the aortic arch of HL animals. Immuno-detection of CP evidences a colocalization with the native LDL-DiI accumulation and the oxLDL deposits in the affected intima of aortic arch from HL animals.
The localization of both native LDL-DiI and oxLDL is limited in the intima by the internal elastic lamina. The immunoreactive CP decorating the thickened intima and fatty streaks of the aorta co-localized with oxLDL and transcytosed native LDL-DiI, suggesting that LDL, which is intensively transported through the activated endothelium, could be modified in the arterial wall by the existent CP.
The fatty streak areas contain macrophages which are able to generate and release ceruloplasmin [10] in the milieu. It is well known that peroxynitrite, which can be also generated by macrophages, is able to release copper from ceruloplasmin [25] , and the resulting free copper is highly effective at inducing lipid peroxidation [26] . Thus, the ceruloplasmin sources for LDL oxidation in the arterial wall are the blood, by an increased transport through the endothelium, and the monocyte-derived macrophages that are located into the subendothelial space following the endothelium activation.
In conclusion, our data demonstrate that CP, either intact or slightly degraded, has a significant oxidation potential against LDL at neutral pH and that hyperlipemia-induced enhanced permeability of the endothelium leads to the accumulation of both LDL and CP in the arterial intima, enabling the subendothelial oxidation of LDL. Thus, the widely used model of in vitro copper oxidized LDL for studies of initiation and progression of fatty streaks and atherosclerotic plaques, could be acknowledged as an in vivo alteration of LDL.
